Skip to main content
Journal ArticleOPEN ACCESS

Transforming growth factor a 1: In situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon

Gut (1993) 34(2 SUPPL)
DOI: 10.1136/gut.34.2_Suppl.S146
25Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

In a semiquantitative assessment of the expression of transforming growth factor (TGF) β1 in liver biopsy specimens from patients with chronic hepatitis C, treatment with interferon alfa-2b (3 million units (MU) three times weekly) decreased the expression of TGF β1 in six of seven patients. The reduction in TGF ,β1 correlated significantly with the scores for inflammation (p<005) and necrosis (p

Cite

CITATION STYLE

APA

Bedossa, P., Poynard, T., Mathurin, P., Lemaigre, G., & Chaput, J. C. (1993). Transforming growth factor a 1: In situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon. Gut, 34(2 SUPPL). https://doi.org/10.1136/gut.34.2_Suppl.S146

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free